title: Treatment of Schamberg's disease with pentoxifylline--therapeutic trial.
abstract: Twenty patients with Schamberg's disease were started on pentoxifylline (400 mg once daily) for a period of 8 weeks. Improvement was assessed at 2 weekly intervals by two observers independently and graded as mild (< 25%, moderate (25-50%) and marked (>50%). Marked improvement was observed in 10/20(50%) patients. We conclude that pentoxifylline should be considered as first line therapy in all patients with Schamberg's disease.
authors.affiliation: Department of Dermatology and STD UCMS >B Hospital, Shahdara, Delhi-110 095, India.
authors.forename: V
authors.initials: V
authors.lastname: Gandhi
authors.forename: A
authors.initials: A
authors.lastname: Singal
authors.forename: B
authors.initials: B
authors.lastname: Sachdeva
authors.forename: S N
authors.initials: SN
authors.lastname: Bhattacharya